Venus Remedies Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth from ₹95.15 Cr to ₹167.72 Cr indicates strong demand and market expansion.
Net profit surged to ₹19.60 Cr in Q4, showcasing effective cost management and operational efficiency.
Robust operating profit margin of 13.55% in Q4 suggests improved profitability compared to previous quarters.

NEGATIVES

Expenses increased significantly in Q4, impacting profit growth despite high revenues.
Operating profit margin dipped in Q1, reflecting initial operational challenges and higher material costs.
Tax liability decreased in Q4, but inconsistent tax rates raise concerns over future profit stability.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	95.15	167.72	143.42	195.16	108.61	167.45	176.86	131.90
Expenses	92.36	156.43	137.99	181.61	103.35	168.96	163.92	127.99
Operating Profit	2.79	11.29	5.43	13.55	5.26	-1.51	12.94	3.91
Other Income	2.26	3.05	2.35	3.92	1.59	10.58	2.03	8.69
Interest	0.06	0.06	0.07	0.02	0.02	0.02	0.01	0.01
Depreciation	7.55	6.44	6.54	5.91	5.98	6.40	5.41	6.18
Profit Before Tax	5.05	14.34	7.78	17.47	6.85	9.07	24.88	12.60
Tax	3.87	4.40	0.93	6.96	5.63	5.56	5.28	3
Net Profit	1.18	9.94	6.85	10.51	1.22	3.51	19.60	9.60
Eps in Rs	0.88	7.44	5.13	7.86	0.92	2.63	14.66	7.18